Big Pharma Split Corp Class A (PRM) — Cash Flow Reinvestment Rate
Big Pharma Split Corp Class A (PRM) has a Cash Flow Reinvestment Rate of 0.00x as of September 2023, reinvesting CA$0.00 (capex CA$0.00 ) from operating cash flow of CA$644.28K. See Big Pharma Split Corp Class A free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Big Pharma Split Corp Class A Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Big Pharma Split Corp Class A across 5 annual periods. For the full cash flow conversion analysis, see PRM operating cash flow.
Annual Cash Flow Reinvestment Rate for Big Pharma Split Corp Class A (2018–2023)
Year-by-year capital reinvestment analysis for Big Pharma Split Corp Class A. See financial flexibility index of Big Pharma Split Corp Class A to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.00x | CA$3.00 | CA$11.86 Million | CA$3.00 | — |
| 2022 | 0.00x | CA$0.00 | CA$1.13 Million | CA$0.00 | ▼ -100.0% |
| 2020 | 0.00x | CA$3.00 | CA$4.35 Million | CA$3.00 | — |
| 2019 | 0.00x | CA$0.00 | CA$8.68 Million | CA$0.00 | — |
| 2018 | 0.00x | CA$0.00 | CA$1.27 Million | CA$0.00 | — |